Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) announced that Richard Peters, M.D., Ph.D., has been appointed as the Company's President and Chief ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE